[Federal Register Volume 69, Number 50 (Monday, March 15, 2004)]
[Notices]
[Pages 12165-12166]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-5806]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Director, National Institutes of Health; Notice of 
Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of 
the Office of AIDS Research Advisory Council.
    The meeting will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the Contact Person listed below in 
advance of the meeting.

    Name of Committee: Office of AIDS Research Advisory Council.
    Date: April 8-9, 2004.
    Time: 9 a.m. to 12 p.m.
    Agenda: A Report of the Director addressing OAR initiatives. The 
meeting will focus on current progress and scope of HIV/AIDS vaccine 
research, development, and clinical testing.
    Place: National Institutes of Health. Building 31, 31 Center 
Drive, Room 6C10, Bethesda, MD 20892.
    Contact Person: Jack Whitescarver, Director, Office of AIDS 
Research, OD, National Institutes of Health, 9000 Rockville Pike, 
Building 2, Room 4E14, Bethesda, MD 20892, (301) 496-0357.
    Information is also available on the Institute's/Center's Home 
page: http://www.nih.gov/od/oar/index.htm, where an agenda and any 
additional information for the meeting will be posted when 
available.
    Any member of the public interested in presenting oral comments 
to the committee

[[Page 12166]]

may notify the Contact Person listed on this notice at least 10 days 
in advance of the meeting. Interested individuals and 
representatives of organizations may submit a letter of intent, a 
brief description of the organization represented, and a short 
description of the oral presentation. Only one representative of an 
organization may be allowed to present oral comments and if accepted 
by the committee, presentations may be limited to five minutes. Both 
printed and electronic copies are requested for the record. In 
addition, any interested person may file written comments with the 
committee by forwarding their statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.

(Catalogue of Federal Domestic Assistance Program Nos. 93.14, 
Intramural Research Training Award; 93.22, Clinical Research Loan 
Repayment Program for Individuals from Disadvantaged Backgrounds; 
93.232, Loan Repayment Program for Research Generally; 93.39, 
Academic Research Enhancement Award; 93.936, NIH Acquired 
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187, 
Undergraduate Scholarship Program for Individuals from Disadvantaged 
Backgrounds, National Institutes of Health, HHS)

    Dated: March 9, 2004.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 04-5806 Filed 3-12-04; 8:45 am]
BILLING CODE 4140-01-M